These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 16824410

  • 21. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
    Sancho JM, Ribera JM, Oriol A, Hernandez-Rivas JM, Rivas C, Bethencourt C, Parody R, Deben G, Bello JL, Feliu E, Programa para el Estudio y Tratamiento de Hemopatias Malignas Group.
    Cancer; 2006 Jun 15; 106(12):2540-6. PubMed ID: 16700036
    [Abstract] [Full Text] [Related]

  • 22. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.
    Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Lafage-Pochitaloff M, Chassevent A, Lhéritier V, Macintyre E, Béné MC, Ifrah N, Dombret H.
    J Clin Oncol; 2009 Feb 20; 27(6):911-8. PubMed ID: 19124805
    [Abstract] [Full Text] [Related]

  • 23. Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol.
    Toft N, Birgens H, Abrahamsson J, Bernell P, Griškevičius L, Hallböök H, Heyman M, Holm MS, Hulegårdh E, Klausen TW, Marquart HV, Jónsson OG, Nielsen OJ, Quist-Paulsen P, Taskinen M, Vaitkeviciene G, Vettenranta K, Åsberg A, Schmiegelow K.
    Eur J Haematol; 2013 May 20; 90(5):404-12. PubMed ID: 23461707
    [Abstract] [Full Text] [Related]

  • 24. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM, Ribera JM, Xicoy B, Morgades M, Oriol A, Tormo M, del Potro E, Debén G, Abella E, Bethencourt C, Ortín X, Brunet S, Ortega-Rivas F, Novo A, López R, Hernández-Rivas JM, Sanz MA, Feliu E, PETHEMA Group.
    Eur J Haematol; 2007 Feb 20; 78(2):102-10. PubMed ID: 17087744
    [Abstract] [Full Text] [Related]

  • 25. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD, Thomas AJ, Wagner JE, Weisdorf D, Luo X, DeFor TE, Verneris MR, Dusenbery KE, MacMillan ML, Tolar J, Baker KS, Orchard PJ.
    Biol Blood Marrow Transplant; 2008 Jun 20; 14(6):685-92. PubMed ID: 18489994
    [Abstract] [Full Text] [Related]

  • 26. Treatment of acute lymphoblastic leukaemia in adults with modified BFM regimen.
    Kudva GC, Chandy M, Dennison D, Srivastava A, Bhushan V.
    Indian J Cancer; 1994 Mar 20; 31(1):1-7. PubMed ID: 8063329
    [Abstract] [Full Text] [Related]

  • 27. Clinical characteristics, biologic features and outcome for young adult patients with acute lymphoblastic leukaemia.
    Nachman J.
    Br J Haematol; 2005 Jul 20; 130(2):166-73. PubMed ID: 16029445
    [Abstract] [Full Text] [Related]

  • 28. Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.
    Koumarianou AA, Xiros N, Papageorgiou E, Pectasides D, Economopoulos T.
    Anticancer Res; 2007 Jul 20; 27(2):1191-7. PubMed ID: 17465262
    [Abstract] [Full Text] [Related]

  • 29. Prognostic factors and outcome of therapy in adult acute lymphoblastic leukemia.
    Philips GK, Crowell EB, Mani A.
    Indian J Cancer; 1991 Sep 20; 28(3):148-54. PubMed ID: 1786981
    [Abstract] [Full Text] [Related]

  • 30. [Survival in adults with acute lymphoblastic leukaemia].
    Tangen JM, Fløisand Y, Haukås E, Naess IA, Skjelbakken T, Stapnes C, Tjønnfjord GE.
    Tidsskr Nor Laegeforen; 2010 Sep 09; 130(17):1710-3. PubMed ID: 20835280
    [Abstract] [Full Text] [Related]

  • 31. [Treatment results in children with the standard risk acute lymphoblastic leukemia treated with high dose of methotrexate (5.0 g/m2). 11 years of the Polish Pediatric Leukemia/Lymphoma Study Group experience].
    Derwich K, Wachowiaki J, Kaczmarek-Kanoldi M, Balcerska A, Balwierz W, Chybicka A, Kowalczyk JR, Matysiak M, Jackowska T, Sońta-Jakimczyk D, Wysocki M, Chełmecka-Hanuszewicz L, Cwiklińska M, Kołtan A, Malinowska I, Odój T, Płoszyńska A, Steczowicz M, Wojciechowska V, Wójtowicz A, Polish Pediatric Leukemia/Lymphoma Study Group.
    Przegl Lek; 2006 Sep 09; 63(1):7-10. PubMed ID: 16892891
    [Abstract] [Full Text] [Related]

  • 32. Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols.
    Barry E, DeAngelo DJ, Neuberg D, Stevenson K, Loh ML, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin M, Cohen HJ, Sallan SE, Silverman LB.
    J Clin Oncol; 2007 Mar 01; 25(7):813-9. PubMed ID: 17327603
    [Abstract] [Full Text] [Related]

  • 33. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.
    Barredo JC, Devidas M, Lauer SJ, Billett A, Marymont M, Pullen J, Camitta B, Winick N, Carroll W, Ritchey AK.
    J Clin Oncol; 2006 Jul 01; 24(19):3142-9. PubMed ID: 16809737
    [Abstract] [Full Text] [Related]

  • 34. [Effect of prognostic factors on the course of acute lymphoblastic leukemia in children].
    Rokicka-Milewska R, Derulska D, Lewicki Z.
    Pediatr Pol; 1988 Nov 01; 63(11):703-15. PubMed ID: 3253657
    [No Abstract] [Full Text] [Related]

  • 35. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K, Konstantynowicz J, Krawczuk-Rybak M.
    Pol Merkur Lekarski; 2007 Oct 01; 23(136):271-5. PubMed ID: 18293849
    [Abstract] [Full Text] [Related]

  • 36. [Treatment of acute lymphoblastic leukemia in children. Results of the FRALLE 83 protocol].
    Bancillon A.
    Arch Fr Pediatr; 1991 Oct 01; 48(8):593-4. PubMed ID: 1768205
    [No Abstract] [Full Text] [Related]

  • 37. [Acute lymphoblastic leukemia in children. A retrospective study: 1970-1991].
    Schmiegelow K, Yssing M, Hertz H, Scherling B, Holm K, Schmiegelow M.
    Ugeskr Laeger; 1995 Jan 02; 157(1):41-6. PubMed ID: 7839546
    [Abstract] [Full Text] [Related]

  • 38. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
    Creutzig U, Büchner T, Sauerland MC, Zimmermann M, Reinhardt D, Döhner H, Schlenk RF.
    Cancer; 2008 Feb 01; 112(3):562-71. PubMed ID: 18076087
    [Abstract] [Full Text] [Related]

  • 39. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Ochocka M, Zelenay E.
    Pediatr Pol; 1988 Nov 01; 63(11):716-22. PubMed ID: 3253658
    [No Abstract] [Full Text] [Related]

  • 40. Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
    Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE, Asselin BL.
    J Clin Oncol; 2003 Oct 01; 21(19):3616-22. PubMed ID: 14512392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.